These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29253120)

  • 1. Long-term outcome of epicardial implantable cardioverter-defibrillator systems in children: results justify its preference in paediatric patients.
    Winkler F; Dave H; Weber R; Gass M; Balmer C
    Europace; 2018 Sep; 20(9):1484-1490. PubMed ID: 29253120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach.
    Schneider AE; Burkhart HM; Ackerman MJ; Dearani JA; Wackel P; Cannon BC
    Heart Rhythm; 2016 Sep; 13(9):1905-12. PubMed ID: 27321244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years.
    Tomaske M; Prêtre R; Rahn M; Bauersfeld U
    Europace; 2008 Oct; 10(10):1152-6. PubMed ID: 18701602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subxiphoid approach to epicardial implantation of implantable cardioverter defibrillators in children.
    Haydin S; Saygi M; Ergul Y; Ozyilmaz I; Ozturk E; Akdeniz C; Tuzcu V
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):926-30. PubMed ID: 23668428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term single-center experience of defibrillator therapy in children and adolescents.
    Frommeyer G; Feder S; Bettin M; Debus V; Köbe J; Reinke F; Uebing A; Eckardt L; Kehl HG
    Int J Cardiol; 2018 Nov; 271():105-108. PubMed ID: 29885825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillator implantation in children in The Netherlands.
    Ten Harkel AD; Blom NA; Reimer AG; Tukkie R; Sreeram N; Bink-Boelkens MT
    Eur J Pediatr; 2005 Jul; 164(7):436-41. PubMed ID: 15843980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children.
    Müller MJ; Dieks JK; Backhoff D; Schneider HE; Ruschewski W; Tirilomis T; Paul T; Krause U
    J Interv Card Electrophysiol; 2019 Mar; 54(2):151-159. PubMed ID: 30255451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicardial vs. transvenous implantable cardioverter defibrillators in children.
    Le Bos PA; Pontailler M; Maltret A; Kraiche D; Gaudin R; Barbanti C; Marijon E; Raisky O; Bonnet D; Waldmann V
    Europace; 2023 Mar; 25(3):961-968. PubMed ID: 36735263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
    Magnusson P; Gadler F; Liv P; Mörner S
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study.
    Zienciuk-Krajka A; Sterliński M; Filipecki A; Owczuk R; Bednarek J; Kempa M; Sielski S; Dziduszko M; Mitkowski P; Kaźmierczak J; Kuśnierz J; Michałkiewicz D; Stec SM; Gułaj M; Majcherek R; Lubiński A; Raczak G
    Kardiol Pol; 2018; 76(12):1687-1696. PubMed ID: 30251242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.
    DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The subcutaneous cardioverter-defibrillator: When less is more].
    Kuschyk J; Rudic B; Akin I; Borggrefe M; Röger S
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):123-8. PubMed ID: 26058997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.